Company Filing History:
Years Active: 2018
Title: Kyung Hee Nahm: Innovator in Dual-Target Antibody Development
Introduction
Kyung Hee Nahm is a prominent inventor based in Daejeon, South Korea. He has made significant contributions to the field of biotechnology, particularly in the development of dual-target antibodies. With a total of 2 patents, his work is paving the way for advancements in pharmaceutical compositions.
Latest Patents
Kyung Hee Nahm's latest patents include a novel form of a dual-target antibody that targets VEGFR-2 and DLL4. This invention encompasses a gene encoding the antibody, a recombinant expression vector that includes the gene, and host cells transformed with this vector. Additionally, it outlines a method for producing the dual-target antibody using these host cells, along with a pharmaceutical composition that comprises the dual-target antibody.
Career Highlights
Nahm is currently associated with Pharmabcine Inc., where he continues to innovate in the field of antibody development. His work is crucial in addressing various medical challenges through targeted therapies.
Collaborations
Some of his notable coworkers include Joong Kyu Kim and Jin San Yoo, who contribute to the collaborative efforts in research and development at Pharmabcine Inc.
Conclusion
Kyung Hee Nahm's contributions to the field of biotechnology, particularly through his dual-target antibody inventions, highlight his role as a key innovator. His work not only advances scientific knowledge but also has the potential to improve therapeutic options for patients.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.